Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway

Biochemical and Biophysical Research Communications

Volumn 331, Issue 4, 2005, Pages 1245-1252

  Sen, Sudip ^a   Sharma, Himani ^a   Singh, Neeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Chemotherapy; Curcumin; Mitochondrial pathway; NSCLC; Vinorelbine

Indexed keywords

CASPASE 3; CASPASE 9; CURCUMIN; CYCLOOXYGENASE 2; CYTOCHROME C; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NAVELBINE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

APOPTOSIS; ARTICLE; CANCER CELL; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG POTENCY; DRUG SENSITIZATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CASPASE 9; CASPASES; CELL LINE, TUMOR; CURCUMIN; DOWN-REGULATION; DRUG SYNERGISM; HUMANS; LUNG NEOPLASMS; MITOCHONDRIA; NF-KAPPA B; TRANSCRIPTION FACTOR AP-1; VINBLASTINE;

EID: 18844461634     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.04.044     Document Type: Article

References (38)

1. Park. Epidemiology of chronic non-communicable diseases and conditions, in: Park's Textbook of Preventive and Social Medicine 17th edn. M/s Banarsidas Bhanot Publishers, Jabalpur, India, 2002, pp. 285-294
2. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomised clinical trials. Br. Med. J. 311 (1995) 899-909
3. F. Oshita, T. Kurata, T. Kasai, M. Fakuda, N. Yamamoto, and Y. Ohe Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions Jpn. J. Cancer Res. 86 1995 1198 1202
4. I.S. Fentiman, U. Tirelli, S. Monfardini, M. Schneider, J. Festen, and F. Cognetti Cancer in the elderly: why so badly treated? Lancet 28 1990 1020 1022
5. S. Monfardini, and R. Yancik Cancer in the elderly: meeting the challenge of an aging population J. Natl. Cancer Inst. 85 1993 532 538
6. J.C. Soria, J.Y. Douillar, and J.L. Pujol Prognostic analysis of survival in the European randomized trial comparing navelbine (NVB) vs. navelbine cisplatin (NVB-P) vs. vindesine cisplatin (VDS-P) Proc. Am. Soc. Clin. Oncol. 18 1999 491a
7. P.A. Bunn Jr. Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why? J. Clin. Oncol. 20 2002 23S 33S
8. R.O. Dillman, S.L. Seagren, K.J. Propert, J. Guerra, W.L. Eaton, and M.C. Perry A randomized trial of induction chemotherapy plus high-dose radiation vs. radiation alone in stage III non-small-cell lung cancer N. Engl. J. Med. 323 1990 940 945
9. H.P. Ammon, and M.A. Wahl Pharmacology of Curcuma longa Planta Med. 57 1991 1 7
10. M.T. Huang, Z.Y. Wang, C.A. Georgiadis, J.D. Laskin, and A.H. Conney Inhibitory effects of Curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene Carcinogenesis 13 1992 2183 2186
11. M.T. Huang, R.C. Smart, C.Q. Wong, and A.H. Conney Inhibitory effect of Curcumin, chlorogenic acid, caffeic acid and ferulic acid on tumor promotion in mouse skin by 12-O-tetradecanoylphorbol-13-acetate Cancer Res. 48 1998 5941 5946
12. M.C. Jiang, H.F. Yang-Yen, J.J. Yen, and J.K. Lin Curcumin induces apoptosis in immortalized NIH 3T3 and malignant cancer cell lines Nutr. Cancer 26 1996 111 120
13. Y.R. Chen, and T.H. Tan Inhibition of the c-Jun N-terminal kinase (JNK) signaling pathway by Curcumin Oncogene 17 1998 173 178
14. L. Korutla, J.Y. Cheung, J. Mendelsohn, and R. Kumar Inhibition of ligand-induced activation of epidermal growth factor receptor tyrosine phosphorylation by Curcumin Carcinogenesis 16 1995 1741 1745
15. S. Singh, and B.B. Aggarwal Activation of transcription factor NF-kappaB is suppressed by Curcumin (diferuloyl-methane) J. Biol. Chem. 270 1995 24995 25000
16. T.S. Huang, S.C. Lee, and J.K. Lin Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells Proc. Natl. Acad. Sci. USA 88 1991 5292 5296
17. N. Singh, N. Khanna, H. Sharma, S. Kundu, and S. Azmi Insights into the molecular mechanism of apoptosis induced by TNF-alpha in mouse epidermal JB6-derived RT-101 cells Biochem. Biophys. Res. Commun. 295 2002 24 30
18. V.G. Reddy, N. Khanna, and N. Singh Vitamin C augments chemotherapeutic response of cervical carcinoma HeLa cells by stabilizing P53 Biochem. Biophys. Res. Commun. 282 2001 409 415
19. H. Sharma, S. Sen, M. Mathur, S. Bahadur, and N. Singh Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers Head Neck 26 2004 733 740
20. G.D. Diaz, Q. Li, and R.H. Dashwood Caspase-8 and apoptosis-inducing factor mediate a cytochrome c independent pathway of apoptosis in human colon cancer cells induced by the dietary phytochemical chlorophyllin Cancer Res. 63 2003 1254 1261
21. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of Curcumin: preclinical and clinical studies Anticancer Res. 23 2003 363 398
22. S. Somasundaram, N.A. Edmund, D.T. Moore, G.W. Small, Y.Y. Shi, and R.Z. Orlowski Dietary Curcumin inhibits chemotherapy-induced apoptosis in models of human breast cancer Cancer Res. 62 2002 3868 3875
23. M. Muller, S. Strand, H. Hug, E.M. Heinemann, H. Walczak, and W.J. Hofmann Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand system and involves activation of wild-type p53 J. Clin. Invest. 99 1997 403 413
24. D. Morin, S. Barthelemy, R. Zini, S. Labidalle, and J.P. Tillement Curcumin induces the mitochondrial permeability transition pore mediated by membrane protein thiol oxidation FEBS Lett. 495 2001 131 136
25. K. Piwocka, K. Zablocki, M.R. Wieckowski, J. Skierski, I. Feiga, and J. Szopa A novel apoptosis-like pathway, independent of mitochondria and caspases, induced by Curcumin in human lymphoblastoid T (Jurkat) cells Exp. Cell Res. 249 1999 299 307
26. J.C. Reed Bcl-2 family proteins Oncogene 17 1998 3225 3236
27. R. Silvestrini, A. Costa, C. Lequaglie, C. Mochen, S. Veneroni, and M. Leutner Bcl-2 protein and prognosis in patients with potentially curable non-small-cell lung cancer Virchows Arch. 432 1998 441 444
28. J. Yang, X. Liu, K. Bhalla, C.N. Kim, A.M. Ibrado, and J. Cai Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked Science 275 1997 1129 1132
29. R.J. Anto, A. Mukhopadhyay, K. Denning, and B.B. Aggarwal Curcumin (diferuloylmethane) induces apoptosis through activation of caspase-8, BID cleavage and cytochrome c release: its suppression by ectopic expression of Bcl- 2 and Bcl-xl Carcinogenesis 23 2002 143 150
30. J.A. Bush, K.J. Cheung Jr., and G. Li Curcumin induces apoptosis in human melanoma cells through a Fas receptor/caspase-8 pathway independent of p53 Exp. Cell Res. 271 2001 305 314
31. A. Klopfer, A. Hasenjager, C. Belka, K. Schulze-Osthoff, B. Dorken, and P.T. Daniel Adenine deoxynucleotides fludarabine and cladribine induce apoptosis in a CD95/Fas receptor, FADD and caspase-8-independent manner by activation of the mitochondrial cell death pathway Oncogene 23 2004 9408 9418
32. H. Ding, C. Han, J. Zhu, C.S. Chen, and S.M. D'Ambrosio Celecoxib derivatives induce apoptosis via the disruption of mitochondrial membrane potential and activation of caspase 9 Int. J. Cancer 113 2005 803 810
33. H. Safran, T. King, H. Choy, A. Gollerkeri, H. Kwakwa, and F. Lopez p53 mutations do not predict response to paclitaxel/radiation for nonsmall cell lung carcinoma Cancer 78 1996 1203 1210
34. B.B. Aggarwal Apoptosis and nuclear factor-kappa B: a tale of association and dissociation Biochem. Pharmacol. 60 2000 1033 1039
35. D. Karunagaran, and B.B. Aggarwal Transcription factors as targets for the drug development G. Keri I. Toth Molecular Pathomechanisms and New Trends in Drug Development 2002 Harwood Academic Publisher New York 76 91
36. S.M. Plummer, K.A. Holloway, M.M. Manson, R.J. Munks, A. Kaptein, and S. Farrow Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent Curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex Oncogene 18 1999 6013 6020
37. F. Zhang, N.K. Altorki, J.R. Mestre, K. Subbaramaiah, and A.J. Dannenberg Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells Carcinogenesis 20 1999 445 451
38. C.S. Williams, M. Tsujii, J. Reese, S.K. Dey, and R.N. DuBois Host cyclooxygenase-2 modulates carcinoma growth J. Clin. Invest. 105 2000 1589 1594